FDA Approves First-In-Class Non-Opioid Medication

It will come as a 50-milligram prescription pill which contains the drug suzetrigene.

The FDA has approved a first-in-class non-opioid medication.

‘Jurnavix’ was tested through two random controlled trials of acute surgical pain. Both trials showed significant superior reduction in pain with Jurnavix compared to a Placebo.

It will come as a 50-milligram prescription pill which contains the drug suzetrigene. The tablets will be taken every 12-hours after a larger starter dose and are only available for adults.

The new non-opioid option offers an opportunity to mitigate certain risks associated with using an opioid for pain and provides patients with another treatment choice.